These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1971217)

  • 21. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A; Palm D; Pitschner HF; Belz GG
    Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol.
    Losa C; Marchal-Heussler L; Orallo F; Vila Jato JL; Alonso MJ
    Pharm Res; 1993 Jan; 10(1):80-7. PubMed ID: 8094245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate.
    Drago F; Emmi I; Marino V
    Pharmacol Res; 1997 Apr; 35(4):299-302. PubMed ID: 9264045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BM 12.434, a novel compound with vasodilating and beta-adrenoceptor-blocking activities.
    von Möllendorff E; Huschka C; Schröter E; Abshagen U
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():477s-479s. PubMed ID: 6119183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence of two atenolol formulations in healthy volunteers. Evaluation and prediction of effect kinetics at beta-adrenoceptors in vivo by means of a radioreceptor assay.
    Sitzler G; Heibel B; Lücker PW; Palm D
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):129-37. PubMed ID: 1677061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of the beta-receptor blocker metipranolol in patients with liver cirrhosis (author's transl)].
    Seyfried C; Ledermann H; Rennekamp H; L'age M; Abshagen U
    Dtsch Med Wochenschr; 1982 Jan; 107(1):21-6. PubMed ID: 6120063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study.
    Kim YH; Choi HY; Noh YH; Lee SH; Lim HS; Kim C; Bae KS
    Drug Des Devel Ther; 2015; 9():2911-8. PubMed ID: 26089641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metipranolol--a new beta-blocker].
    Kruse W
    Klin Monbl Augenheilkd; 1983 Jun; 182(6):582-4. PubMed ID: 6135820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.
    Ferguson RK; Vlasses PH; Koplin JR; Holmes GI; Huber P; Demetriades J; Abrams WB
    Br J Clin Pharmacol; 1982 Nov; 14(5):719-25. PubMed ID: 6128021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the strength, drop size and viscosity of metipranolol eye drops on the concentration of the substance in human aqueous humour.
    Kessler C; Bleckmann H; Kleintges G
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):452-6. PubMed ID: 1682221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross-over study.
    Neuvonen PJ; Pentikäinen PJ; Jounela AJ
    Br J Clin Pharmacol; 1978 Oct; 6(4):363-7. PubMed ID: 29653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of three concentrations of beta-blocker eyedrops. Criteria for choosing and efficacy].
    de Galleani B
    Ophtalmologie; 1989; 3(3):220-2. PubMed ID: 2577054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
    Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
    Bartsch W; Sponer G; Dietmann K
    Arzneimittelforschung; 1977; 27(12):2319-22. PubMed ID: 23798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.